September 18, 2014 3:28 AM ET

Pharmaceuticals

Company Overview of Acretia, Inc.

Company Overview

Acretia, Inc., a drug development company, engages in the development of a product for hyper-proliferative inflammatory diseases of the skin. It focuses on the late stage biopharmaceutical compounds. The company identifies and acquires pharmaceutical products from medical institutions; establishes partnerships with biotechnology and pharmaceutical companies to validate the clinical utility of its products; and commercializes and markets via alliances with pharmaceutical partners. It also develops products targeting unmet needs in relieving pain. The company was incorporated in 2003 and is based in Lexington, Massachusetts.

51 Follen Road

Lexington, MA 02421

United States

Founded in 2003

Phone:

781-652-0200

Fax:

270-913-2761

Key Executives for Acretia, Inc.

Chief Executive Officer and President
Vice President of Finance
Head of Medical Affairs
Head of Formulation Development and Assurance
Age: 51
Head of Preclinical and Regulatory
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
KCI International, Inc. United States
Purdue Pharma L.P. United States
Mintiva Holdings, L.L.C. United States
Altaire Pharmaceuticals, Inc. United States
Synthon Chiragencies Corporation United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Acretia, Inc., please visit www.acretia.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.